Shenzhen Neptunus Interlong Bio-technique Dividends and Buybacks
Dividend criteria checks 0/6
Shenzhen Neptunus Interlong Bio-technique is a dividend paying company with a current yield of 1.52%.
Key information
1.5%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 34% |
Recent dividend and buyback updates
Recent updates
Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Shares Climb 74% But Its Business Is Yet to Catch Up
Apr 16
There Is A Reason Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Price Is Undemanding
Feb 26Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Nov 07Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings
Sep 05We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings
Apr 19These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely
Oct 03Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?
Mar 29We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt
Sep 28A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Aug 18Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?
Jun 06Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Dec 15Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.
Dec 29Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly
Nov 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 8329 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 8329 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Shenzhen Neptunus Interlong Bio-technique Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (8329) | 1.5% |
| Market Bottom 25% (HK) | 3.0% |
| Market Top 25% (HK) | 7.9% |
| Industry Average (Pharmaceuticals) | 2.8% |
| Analyst forecast (8329) (up to 3 years) | n/a |
Notable Dividend: 8329's dividend (1.52%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.01%).
High Dividend: 8329's dividend (1.52%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.9%).
Earnings Payout to Shareholders
Earnings Coverage: 8329 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: 8329 is not paying a notable dividend for the Hong Kong market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/25 16:38 |
| End of Day Share Price | 2025/04/25 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shenzhen Neptunus Interlong Bio-technique Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.